Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visualizing beta cells after gestational diabetes
2024-520392-27-00Phase 2Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of exenatide in gestational diabetes mellitus (GDM) (2 arms), sponsored by Radboud University Medical Center. Planned start Jan 2025; status: authorised.
02
Drugs
exenatide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2024-520392-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520392-27-00.